Is Algae The Answer To Carbon Capture? Intrinsic Foundries’ Green Fix For Toxic Waste

Why It Matters

By converting emissions into high‑value products, Intrinsic could make CCUS financially viable, accelerating decarbonisation for heavy industry and supporting India’s net‑zero ambitions.

Key Takeaways

• Raised $1.5 M seed round from Transition VC.
• Pilot captured 85‑90% CO₂, yielded 3 kg algae biomass.
• 3D‑printed reactors replace 15 ponds, cut space and contamination.
• Buyback model pays firms for harvested algae biomass.
• India earmarked $2.4 B for CCUS scaling by 2050.

Pulse Analysis

Algae‑driven carbon capture is gaining traction as a low‑energy, high‑throughput alternative to conventional CCUS systems that rely on costly solvents and high‑temperature processes. The rapid growth rate of photosynthetic microbes and their ability to convert CO₂ into complex biomolecules give them a distinct advantage over traditional bacterial platforms. Coupled with rising policy pressure—such as the EU’s carbon border tax and India’s $2.4 billion CCUS allocation—the market is expected to expand to over $6 billion by 2033, creating a fertile environment for deep‑tech innovators.

Intrinsic Foundries differentiates itself through a proprietary extrusion technology that 3‑D‑prints hollow tubular photobioreactors, effectively compressing the footprint of a traditional algae pond by a factor of fifteen. In a recent industrial pilot at a large Indian power plant, the system captured up to 90% of flue‑gas CO₂ and generated three kilograms of algae biomass, which can be refined into premium ingredients like gamma‑linolenic acid and omega‑3 fatty acids. The startup’s dual‑model approach—offering a cost‑sharing buyback option or a licensing arrangement—allows heavy‑emitters to monetize carbon as a feedstock rather than a liability, reshaping the economics of decarbonisation.

If Intrinsic can scale its reactors and secure additional pilots across steel, cement and chemical facilities, it could set a new benchmark for CCUS profitability. Investors are watching closely, as the company’s IP‑centric valuation aligns with global appetite for sustainable, revenue‑generating climate solutions. However, challenges remain in algae strain optimization, supply‑chain integration for biochemicals, and regulatory approval for large‑scale deployment. Success would not only validate algae as a viable CCUS pathway but also accelerate India’s push toward net‑zero emissions before 2070.